anticoagulant

Apixaban 5 mg is an oral anticoagulant (“blood thinner“) commonly used to treat and prevent harmful blood clots, such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). It is also widely used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Rivaroxaban (commonly branded as Xarelto) is a direct oral anticoagulant (blood thinner) used to prevent and treat blood clots, reducing the risk of strokes, pulmonary embolism (PE), and deep vein thrombosis (DVT). It is also used to lower cardiovascular risk in coronary artery disease and after certain joint replacement surgeries.

Rivaroxaban (commonly branded as Xarelto) is a direct oral anticoagulant (blood thinner) used to prevent and treat blood clots, reducing the risk of strokes, pulmonary embolism (PE), and deep vein thrombosis (DVT). It is also used to lower cardiovascular risk in coronary artery disease and after certain joint replacement surgeries.

Apixaban tablets are blood-thinning (anticoagulant) medicine used to prevent and treat harmful blood clots and to lower stroke risk in certain heart conditions such as atrial fibrillation. It must be used only on a doctor’s prescription and under regular medical supervision.Main usesPrevention of stroke and systemic embolism in people with non‑valvular atrial fibrillation (irregular heartbeat).Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of these clots from coming back after initial treatment.Prevention of blood clots in the legs after hip or knee replacement surgery.

Dabigatran is a direct oral anticoagulant (DOAC) used as a blood thinner to:Prevent stroke in patients with non‑valvular atrial fibrillation (AFib) Treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) Reduce the risk of blood clots after hip or knee replacement surgery It works by blocking thrombin, a key clotting protein, helping blood flow smoothly and lowering the risk of heart attack and stroke

Dabigatran is a direct oral anticoagulant (DOAC) used as a blood thinner to:Prevent stroke in patients with non‑valvular atrial fibrillation (AFib) Treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) Reduce the risk of blood clots after hip or knee replacement surgery It works by blocking thrombin, a key clotting protein, helping blood flow smoothly and lowering the risk of heart attack and stroke

Dabigatran is a direct oral anticoagulant (DOAC) used as a blood thinner to:Prevent stroke in patients with non‑valvular atrial fibrillation (AFib) Treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) Reduce the risk of blood clots after hip or knee replacement surgery It works by blocking thrombin, a key clotting protein, helping blood flow smoothly and lowering the risk of heart attack and stroke